Clinical review: Tuberculosis on the intensive care unit

Critical Care

Volumn 17, Issue 5, 2013, Pages

  Hagan, Guy ^a   Nathani, Nazim ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; CORTICOSTEROID; CYCLOSERINE; DEXAMETHASONE; ETHAMBUTOL; ETHIONAMIDE; GAMMA INTERFERON; ISONIAZID; MONTELUKAST; MOXIFLOXACIN; PREDNISOLONE; PROTIONAMIDE; PYRAZINAMIDE; QUINOLONE DERIVATIVE; RIFAMPICIN; STREPTOMYCIN; THALIDOMIDE; TUBERCULOSTATIC AGENT;

ADJUVANT THERAPY; AIRWAY OBSTRUCTION; ALGORITHM; BRONCHOSCOPY; CARDIOGENIC SHOCK; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS LEVEL; CORTICOSTEROID THERAPY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG MONITORING; EXTRAPULMONARY TUBERCULOSIS; GASTRIC SUCTION; HEMOPTYSIS; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOPHYSIS APOPLEXY; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; INTENSIVIST; INTERFERON GAMMA RELEASE ASSAY; INTRACRANIAL TUBERCULOMA; KIDNEY FAILURE; LARYNGEAL TUBERCULOSIS; LIVER FAILURE; LIVER TOXICITY; LUNG TUBERCULOSIS; MENINGITIS; MILIARY TUBERCULOSIS; MIXED INFECTION; MULTIDRUG RESISTANT TUBERCULOSIS; MULTIPLE ORGAN FAILURE; NEPHROTOXICITY; NUCLEIC ACID AMPLIFICATION; PERICARDIAL EFFUSION; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; SPUTUM CULTURE; STEROID THERAPY; STOMACH ABSORPTION; THORAX RADIOGRAPHY; THORAX SURGERY; TRACHEAL ASPIRATION PROCEDURE; TREATMENT OUTCOME; TUBERCULOSIS; RESPIRATORY INSUFFICIENCY; TRENDS;

HUMANS; INTENSIVE CARE UNITS; RESPIRATORY INSUFFICIENCY; TUBERCULOSIS;

EID: 84896318375     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12760     Document Type: Review

References (72)

1. WHO Global tuberculosis report 2012. WHO., http://www.who.int/tb/publications/global_report/en
2. Pedrazzoli D, Fulton N, Anderson L, Lalor M, Abubakar A, Zenna D. Tuberculosis in the UK: 2012 report. , http://www.hpa.org.uk/Publications/InfectiousDiseases/Tuberculosis/1206TBintheUK2012report/
3. Levy H, Kallenbach JM, Feldman C, Thorburn JR, Abramowitz JA. Acute respiratory failure in active tuberculosis. Crit Care Med 1987, 15:221-225. 10.1097/00003246-198703000-00008, 3469061.
4. Silva DR, Menegotto DM, Schulz LF, Gazzana MB, Dalcin PT. Mortality among patients with tuberculosis requiring intensive care:a retrospective cohort study. BMC Infect Dis 2010, 10:54. 10.1186/1471-2334-10-54, 2843613, 20205952.
5. Lin SM, Wang TY, Liu WT. Predictive factors for mortality among non-HIV-infected patients with pulmonary tuberculosis and respiratory failure. Int J Tuberc Lung Dis 2009, 13:335-340.
6. Zahar JR, Azoulay E, Klement E, De L, Lucet JC, Regnier B, Schlemmer B, Bedos JP. Delayed treatment contributes to mortality in ICU patients with severe active pulmonary tuberculosis and acute respiratory failure. Intensive Care Med 2001, 27:513-520. 10.1007/s001340000849, 11355119.
7. Jacob JT, Mehta AK, Leonard MK. Acute forms of tuberculosis in adults. Am J Med 2009, 122:12-17. 10.1016/j.amjmed.2008.09.018, 19114163.
8. Erbes R, Oettel K, Raffenberg M, Mauch H, Schmidt-Ioanas, Lode H. Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care. Eur Resp J 2006, 27:1223-1228.
9. Sydow M, Schauer A, Crozier TA, Burchardi H. Multiple organ failure in generalised disseminated tuberculosis. Respir Med 1992, 86:517-519. 10.1016/S0954-6111(96)80014-X, 1470711.
10. Piqueras AR, Marruecos L, Artigas A, Rodriguez C. Miliary tuberculosis and adult respiratory distress syndrome. Intensive Care Med 1987, 13:175-182.
11. Frame RN, Johnson MC, Eichenhorn MS, Bower GC, Popovich J. Active tuberculosis in the medical intensive care unit:a 15-year retrospective analysis. Crit Care Med 1987, 15:1012-1014. 10.1097/00003246-198711000-00005, 3677743.
12. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R. Surviving Sepsis Campaign:International guidelines for management of severe sepsis and septic shock:2012. Crit Care Med 2013, 41:580-637. 10.1097/CCM.0b013e31827e83af, 23353941.
13. Penner C, Roberts D, Kunimoto D, Manfreda J, Long R. Tuberculosis as a primary cause of respiratory failure requiring mechanical ventilation. Am J Respir Crit Care Med 1995, 151:867-872. 10.1164/ajrccm/151.3_Pt_1.867, 7881684.
14. Kim YJ, Pack KM, Jeong E, Na JO, Oh YM, Lee SD, Kim WS, Kim DS, Kim WD, Shim TS. Pulmonary tuberculosis with acute respiratory failure. Eur Resp J 2008, 32:1625-1630.
15. Ryu YJ, Koh WJ, Kang EH, Suh GY, Chung MP, Kim H, Kwon OJ. Prognostic factors in pulmonary tuberculosis requiring mechanical ventilation for acute respiratory failure. Respirology 2007, 12:406-411. 10.1111/j.1440-1843.2006.01007.x, 17539846.
16. Maartens G, Willcox PA, Benatar SR. Miliary tuberculosis: rapid diagnosis, haematologic abnormalities, and outcome in 109 treated adults. Am J Med 1990, 89:291-296. 10.1016/0002-9343(90)90340-J, 2393033.
17. Hess S, Hospach T, Nossal R, Dannecker G, Magdorf K, Uhlemann F. Life-threatening disseminated tuberculosis as a complication of TNF-α blockade in an adolescent. Eur J Pediatr 2011, 170:1337-1342. 10.1007/s00431-011-1501-y, 21625932.
18. Landouzy L. A note of la typho-bacillose. Lancet 1908, 172:1440-1441.
19. Barber TW, Craven DE, McCabe WR. Bacteremia due to mycobacterium tuberculosis in patients with human immunodeficiency virus infection, A report of 9 cases and a review of the literature. Medicine (Baltimore) 1990, 69:375-383.
20. Lim KH, Chong KL. Multiple organ failure and septic shock in disseminated tuberculosis. Singapore Med J 1999, 40:176-178.
21. Al-Mamari A, Balkhair A, Gujjar A, Ben Abid F, Al-Farqani A, Al-Hamadani A, Jain R. A case of disseminated tuberculosis with adrenal insufficiency. Sultant Qaboos Univ Med J 2009, 9:324-327.
22. Verdon R, Chevret S, Laissy JP, Wolff M. Tuberculous meningitis in adults: review of 48 cases. Clin Infect Dis 1996, 22:982-988. 10.1093/clinids/22.6.982, 8783697.
23. Kumar R, Pandey CK, Bose N, Sahay S. Tuberculous brain abscess:clinical presentation, pathophysiology and treatment (in children). Childs Nerv Syst 2002, 18:118-123. 10.1007/s00381-002-0575-2, 11981617.
24. Thwaites GE, Macmullen-Price J, Tran TH, Pham PM, Nguyen TD, Simmons CP, White NJ, Tran TH, Summers D, Farrar JJ. Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study. Lancet Neurol 2007, 6:230-236. 10.1016/S1474-4422(07)70034-0, 17303529.
25. Figaji AA, Fieggen AG. The neurosurgical and acute care management of tuberculous meningitis: Evidence and current practice. Tuberculosis 2010, 90:393-400. 10.1016/j.tube.2010.09.005, 20970381.
26. Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J. British Infection Society guidelies for the diagnosis and treatment of tuberculosis of the central nervous system in adults and childen. J Infection 2009, 59:167-187.
27. Mathew JM, Rajshekhar V, Chandy MJ. Shunt surgery in poor grade patients with tuberculous meningitis and hydrocephalus:effects of response to external ventricular drainage and other variables on long term outcome. J Neurol Neurosurg Psychiatry 1998, 65:115-118. 10.1136/jnnp.65.1.115, 2170140, 9667572.
28. Moller K, Larsen FS, Bie P, Skinhoj P. The syndrome of inappropriate secretion of antidiuretic hormone and fluid restriction in meningitis-how strong is the evidence?. Scand J Infect Dis 2001, 33:13-26. 10.1080/003655401750064022, 11234973.
29. Figaji AA, Zwane E, Kogels M, Fieggen AG, Argent AC, Le Roux PD, Peter JC. The effect of blood transfusion on brain oxygenation in children with severe traumatic brain injury. Pediatr Crit Care Med 2010, 11:325-331.
30. Axelrod YK, Diringer MN. Temperature management in acute neurologic disorders. Neurol Clin 2008, 26:585-603. 10.1016/j.ncl.2008.02.005, 18514828.
31. National Institue for Health and Clinical Excellence Tuberculosis: Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. National Institue for Health and Clinical Excellence., http://guidance.nice.org.uk/CG117
32. World Health Organisation Treatment of Tuberculosis: guidelines for national programmes; WHO/HTM/TB/2009.420. World Health Organisation., http://www.who.int/tb/publications/tb_treatmentguidelines/en/index.html
33. Shu CC, Lee CH, Wang JY, Jerng JS, Yu CJ, Hsueh PR, Lee LN, Yang PC. Nontuberculous mycobacteria pulmonary infection in medical intensive care unit: the incidence, patient characteristics and clinical significance. Intensive Care Med 2008, 34:2194-2201. 10.1007/s00134-008-1221-6, 18648768.
34. Mase S, Ramsay A, Ng N, Henry M, Hopewell PC, Cunningham J, Urbanczik R, Perkins M, Aziz MA, Pai M. Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis a systematic review. Int J Tuberc Lung Dis 2007, 11:485-495.
35. Jacomelli M, Silva PR, Rodrigues AJ, Demarzo SE, Seicento M, Figueiredo VR. Bronchoscopy for the diagnosis of pulmonary tuberculosis in patients with negative sputum smear microscopy results. J Bras Pneumol 2012, 38:167-173.
36. O'Brien JD, Ettinger NA, Shevlin D, Kollef MH. Safety and yield of transbronchial biopsy in mechanically ventilated patients. Crit Care Med 1997, 25:440-446. 10.1097/00003246-199703000-00012, 9118660.
37. Anderson C, Inhaber N, Menzies D. Comparison of sputum induction with fibre-optic bronchoscopy in the diagnosis of tuberculosis. Am J Resp Crit Care Med 1995, 152:1570-1574. 10.1164/ajrccm.152.5.7582296, 7582296.
38. Thadepalli H, Rambhatla K, Niden AH. Transtracheal aspiration in diagnosis of sputum-smear negative tuberculosis. JAMA 1977, 238:1037-1040. 10.1001/jama.1977.03280110041019, 407374.
39. Jones BE, Young SM, Antoniskis D, Davidson PT, Kramer F, Barnes PF. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993, 148:1292-1297. 10.1164/ajrccm/148.5.1292, 7902049.
40. Pozniak AL, Coyne KM, Miller RF, Lipman MC, Freedman AR, Omerod LP, Johnson MA, Collins S, Lucas SB. British HIV Association guidelines for the treatment of TB/HIV coinfection. HIV Med 2011, 12:517-524. 10.1111/j.1468-1293.2011.00954.x, 21951595.
41. Light RW. Update on pleural effusion. Respirology 2010, 15:451-458. 10.1111/j.1440-1843.2010.01723.x, 20345583.
42. McGrath EE, Anderson PB. Diagnostic tests for tuberculous pleural effusion. Eur J Clin Microbiol Infect Dis 2010, 29:1187-1193. 10.1007/s10096-010-0986-z, 20556468.
43. Alsoub H, Al Alousi FS. Miliary tuberculosis in Qatar: a review of 32 adult cases. Ann Saudi Med 2001, 21:16-20.
44. Kim JH, Langston AA, Gallis HA. Miliary tuberculosis: epidemiology, clinical manifestations, diagnosis and outcome. Rev Infect Dis 1990, 12:583-590. 10.1093/clinids/12.4.583, 2385765.
45. Chierakul N, Anantasetagoon T, Chaiprasert A, Tingtoy N. Diagnostic value of gastric aspirate smear and polymerase chain reaction in smear-negative pulmonary tuberculosis. Respirology 2003, 8:492-496. 10.1046/j.1440-1843.2003.00503.x, 14629654.
46. Bahammam A, Choudhri S, Long R. The validity of acid-fast smears of gastric aspirates as an indicator of pulmonary tuberculosis. Int J Tuberc Lung Dis 1999, 3:62-67.
47. Jones BE, Young SM, Antoniskis D, Davidson PT, Kramer F, Barnes PF. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993, 148:1292-1297. 10.1164/ajrccm/148.5.1292, 7902049.
48. Pai M, Zwerling A, Menzies D. Systemic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008, 149:177-184. 10.7326/0003-4819-149-3-200808050-00241, 2951987, 18593687.
49. Health Protection Agency Health Protection Agency position statement on the use of Interferon Gamma Release Assay (IGRA) tests for Tuberculosis (TB). Health Protection Agency., http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1204186168242
50. Cho K, Cho E, Kwon S, Im S, Sohn I, Song S, Kim H, Kim S. Factors associated with indeterminate and false negative results of QuantiFERON-TB Gold In-Tube Test in active tuberculosis. Tuberc Respir Dis (Seoul) 2012, 72:416-425.
51. Abubakar I, Stagg HR, Whitworth H, Lalvani A. How should I interpret an interferon gamma release assay result for tuberculosis infection?. Thorax 2013, 68:298-301. 10.1136/thoraxjnl-2013-203247, 23400368.
52. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O'Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodrigues C, Alland D, Perkins MD. Rapid molecular detection of tuberculosis and rifampicin resistance. N Engl J Med 2010, 363:1005-1015. 10.1056/NEJMoa0907847, 2947799, 20825313.
53. Wisnivesky JP, Kaplan J, Henschke C, McGinn TG, Crystal RG. Evaluation of clinical parameters to predict mycobacterium tuberculosis in inpatients. Arch Int Med 2000, 160:2471-2476.
54. Hui C, Wu CL, Chan MC, Kuo IT, Chiang CD. Features of severe pneumonia in patients with undiagnosed pulmonary tuberculosis in an intensive care unit. J Formos Med Assoc 2003, 102:563-569.
55. Wu JY, Ku SC, Shu CC, Fan JY, Chen HY, Chen YC, Yu CJ. The role of chest radiography in the suspicion for and diagnosis of pulmonary tuberculosis in intensive care units. Int J Tuberc Lung Dis 2009, 13:1380-1386.
56. Greenberg SD, Frager D, Suster B, Walker S, Stavropoulos C, Rothpearl A. Active pulmonary tuberculosis in patients with AIDS: spectrum of radiographic findings (including a normal appearance). Radiology 1994, 193:115-119.
57. Lee KS, Im JG. CT in adults with tuberculosis of the chest: characteristic findings and role in management. Am J Roentgenol 1995, 164:1361-1367.
58. Thompson JS. The intestinal response to critical illness. Am J Gastroenterol 1995, 90:190-200.
59. Kimberling ME, Phillips P, Patterson P, Hall M, Robinson CA, Dunlap NE. Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients. Chest 1998, 113:1178-1183. 10.1378/chest.113.5.1178, 9596291.
60. Saukkonon JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, Peloquin CA, Gordin FM, Nunes D, Stader DB, Bernardo J, Venkataramanan R, Sterling TR. An Official ATS Statement: Hepatotoxicity of Anti-tuberculosis Therapy. Am J Resp Crit Care Med 2006, 174:935-952. 10.1164/rccm.200510-1666ST, 17021358.
61. Joint Tuberculosis Committee of the British Thoracic Society Chemotherapy and management of tuberculosis in the United Kingdom:recommendations. Thorax 1998, 53:536-548. 1745276, 9797751, Joint Tuberculosis Committee of the British Thoracic Society.
62. Donald PR, Seifart HI. Cerebrospinal fluid concentrations of ethionamide in children with tuberculous meningitis. J Pediatr 1989, 115:483-486. 10.1016/S0022-3476(89)80862-5, 2769511.
63. Milburn H, Ashman N, Davies P, Doffman S, Drobniewski F, Khoo S, Ormerod P, Ostermann M, Snelson C. Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease. Thorax 2010, 65:559-570.
64. Strang JI, Kakaza HH, Gibson DG, Girling DJ, Nunn AJ, Fox W. Controlled trial of prednisolone as adjuvant in treatment of tuberculous constrictive pericarditis in Transke. Lancet 1987, 19:1418-1422.
65. Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC, Nguyen QH, Nguyen TT, Nguyen NH, Nguyen TN, Nguyen NL, Nguyen HD, Vu NT, Cao HH, Tran TH, Pram PM, Nguyen TD, Stepniewska K, White NJ, Tran TH, Farrar JJ. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004, 351:1741-1751. 10.1056/NEJMoa040573, 15496623.
66. Engel ME, Matchaba PT, Volmink J. Corticosteroids for tuberculous pleurisy. Cochrane Database of Syst Rev 2007, CD001876.
67. Dooley DP, Carpenter JL, Rademacher S. Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature. Clin Infect Dis 1997, 25:872-887. 10.1086/515543, 9356803.
68. Critchley JA, Young F, Orton L, Garner P. Corticosteroids for prevention of mortality in people with tuberculosis:a systemic review and meta-analysis. Lancet Infect Dis 2013, 13:223-237. 10.1016/S1473-3099(12)70321-3, 23369413.
69. Bloch S, Wickremasinghe M, Wright A, Rice A, Thompson M, Kon OM. Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction. Eur Resp J 2009, 18:295-299.
70. Cheng SL, Wang HC, Yang PC. Paradoxical response during anti-tuberculosis treatment in HIV negative patients with pulmonary tuberculosis. Int J Tuberc Lung Dis 2007, 11:1290-1295.
71. Nicolls DJ, King M, Holland D, Bala J, del Rio C. Intracranial tuberculomas developing while on therapy for pulmonary tuberculosis. Lancet Infect Dis 2005, 5:795-801. 10.1016/S1473-3099(05)70299-1, 16310151.
72. Schoeman JF, Fieggen G, Seller N, Mandelson M, Hartzenberg B. Intractable intracranial tuberculous infection responsive to thalidomide:report of four cases. J Child Neurol 2006, 21:301-308. 10.1177/08830738060210040801, 16900926.